Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets

  • Abolfazl Aslani Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan, Iran
  • Alireza Ghasemi Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan, Iran
  • Shekofeh Karbasizadeh Esfahani Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan, Iran
Keywords: Tablets, Dimenhydrinate, Motion Sickness, Meniere's Disease


Background: Design, formulation and physicochemical evaluation of dimenhydrinate 25 mg oral tablets that disintegrate in oral cavity in a proper time. This product is easy to use for babies, geriatrics and people who have difficulty in swallowing. Materials and Methods: 31 formulations were designed in 3 categories via Design-Expert software version 7. Group 1 consist of super-disintegrating bases, group 2 consist of effervescent bases and group 3 consist of super-disintegrating and effervescent bases together. Proposed by Design-Expert software, the optimum formulations were selected in each category and the tablets were produced by direct compression method. Tablets evaluated by friability, thickness, hardness, weight variation, drug content, content uniformity, disintegration time, wetting time, dissolution and moisture uptake tests. Results: The angle of repose and compressibility index of formulations were in the range of 24.65-29.08 and 5.02-9.01 % respectively. Thickness, hardness, wetting time, friability and content uniformity of formulations were in the range of 3.36-3.84 mm, 33.25-38.03 N, 19-37 seconds, 0.31-0.42 % and 96.44-99.02 % respectively. Disintegration time of the groups 1, 2 and 3 were in the range of 16-70, 47-72 and 12-35 seconds, respectively. Conclusion: Mixture of powders and orally dispersible tablets passed all tests. The results showed that formulations containing both of super-disintegrants and effervescent bases had better disintegration time compare to other formulations. [GMJ.2018;7:e936]


Konapure SA, Chaudhari PS, Oswal RJ, Kshirsagar SS, Antre RV, Chorage TV. “Mouth dissolving tablets” an innovative technology. Int J Appl Biol Pharm. 2011;2(1):496-504.

Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - a review. Pharm Sci Technolo Today. 2000;3(4):138-45.

Ashish P, Harsoliya M, Pathan J, Shruti S. A review-formulation of mouth dissolving tablet. Int. j. pharmacol and clin sci. 2011;1(1):1-8.

Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets I: An overview of formulation technology. ‎Sci Pharm. 2009;77(2):309-26.

Badgujar BP, Mundada AS. The technologies used for developing orally disintegrating tablets: a review. Acta Pharm. 2011;61(2):117-39.

Brown D. Orally disintegrating tablets-taste over speed. Drug Del Tech. 2003;3(6):58-61.

Food, Administration D. Guidance for industry: orally disintegrating tablets. CDER. 2008.

Preis M, Pein M, Breitkreutz J. Development of a taste-masked orodispersible film containing dimenhydrinate. Pharm J. 2012;4(4):551-62.

Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev. 2002;26(1):61-7.

Jadhav YG, Galgatte UC, Chaudhari PD. Estimation of Dimenhydrinate in Bulk and Pharmaceutical Dosage Form: Method Development and Validation. iajpr. 2013;3(8):7003.

Healthcare MT. USP-DI: Drug Information for the Healthcare Professional. Micromedex; 1974.

Peera NH, Lohithasu D, Sahoo S, Naidu MS, Kumar KM, Kumar VA. Formulation development and evaluation of oral disintegrating tablets of zolmitriptan. Pharm Lett. 2013;5:324-32.

Haller JS, Jr. The United States Pharmacopoeia: its origin and revision in the 19th century. Bull N Y Acad Med. 1982;58(5):480-92.

Pharmacopoeia I. Indian Pharmacopoeia, vol. II. Delhi: The Controller of Publication. 1996:735.

Nawale R, Mohite K. Formulation and evaluation of domperidone orodispersible tablet. Int J Pharm Sci Res. 2013;4(9):3670-7.

Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy: Lea & Febiger Philadelphia; 1976.

Kumar KG, Mahesh E. Formulation and evaluation of montelukast sodium fast dissolving tablets. jbiopharm. 2012;2(14):75.

Srinath K, Chowdary CP, Palanisamy P, Krishna A, Aparna S. Formulation and evaluation of effervescent tablets of paracetamol. INT J Pharm Res Dev. 2011;3(3):76-104.

Saroha K, Kumar G, Paul Y. Formulation and evaluation of fast dissolving tablets of amoxicillin trihydrate using synthetic superdisintegrants. Int J Pharm Bio Sci. 2013;4(1):254-62.

Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS pharmscitech. 2007;8(2):E127-E33.

Aslani A, Fattahi F. Formulation, characterization and physicochemical evaluation of potassium citrate effervescent tablets. Adv Pharm Bull. 2013;3(1):217.

Thakur RR, Kashi M. An unlimited scope for novel formulations as orally disintegrating systems: Present and future prospects. J Appl Pharm Sci. 2011;1(1):13-9.

Kolhe S, More D. Updated review on orally disintergarting tablets: Advancement in current trends. Research J. Science and Tech. 2013;5(4):III.

Prajapati BG, Patel B. Formulation, evaluation and optimization of orally disintegrating tablet of piroxicam. Int J Pharm Tech Res. 2010;2(3):1893-9.

Bansal N, Sharma G. Formulation and evaluation of orally disintegrating tablets of ondansetron hydrochloride using natural superdisintegrants. Int J PharmTech Res. 2011;3:1616-21.

Bhati S, Sethi V. Formulation and evaluation of fast dissolving tablets of metoclopramide hydrochloride using natural sweetening agent of stevia leaf powder. Int J curr Pharm Res. 2013;5(3):31-5.

Tabakhian M, Shahtalebi M, Salehi E, Keshvari M. Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant. J HerbMed Pharmacol. 2014;3(1).

How to Cite
Aslani, A., Ghasemi, A., & Karbasizadeh Esfahani, S. (2018). Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets. Galen Medical Journal, 7, e936.
Original Article